HDAC9 and cancer: Because of the crucial role of HDACs as transcriptional co-repressors in many disease conditions, including cancer, and the effect of their mutation, aberrant expression or deregulation in cancer and other disorders, targeting and inhibiting HDAC activities is increasingly being demonstrated as effective anticancer therapy4,5.